BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 36656211)

  • 1. Correlation NKX2.2 IHC and
    Pasricha S; Pahwa S; Pruthi M; Jajodia A; Gupta G; Sharma A; Durga G; Kamboj M; Tiwari A; Panigrahi M; Mehta A
    Indian J Pathol Microbiol; 2023; 66(1):58-62. PubMed ID: 36656211
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Louati S; Senhaji N; Chbani L; Bennis S
    Dis Markers; 2018; 2018():7971019. PubMed ID: 30319719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.
    Hung YP; Fletcher CD; Hornick JL
    Mod Pathol; 2016 Apr; 29(4):370-80. PubMed ID: 26847175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma.
    Shibuya R; Matsuyama A; Nakamoto M; Shiba E; Kasai T; Hisaoka M
    Virchows Arch; 2014 Nov; 465(5):599-605. PubMed ID: 25031013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
    Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
    Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningeal Ewing Sarcoma/Peripheral PNET: Clinicopathological, Immunohistochemical and FISH study of four cases.
    Ke Ch; Duan Q; Yang H; Zhu F; Yan M; Xu SP; Zhou S; Wan F; Shu K; Lei T; Xia LM
    Neuropathology; 2017 Feb; 37(1):35-44. PubMed ID: 27500883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does PAX7 and NKX2.2 immunoreactivity in Ewing sarcoma have prognostic significance?
    Machado I; Charville GW; Yoshida A; Navarro S; Righi A; Gambarotti M; Scotlandi K; López-Guerrero JA; Llombart-Bosch A
    Virchows Arch; 2022 Apr; 480(4):909-917. PubMed ID: 34985580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FISH for EWSR1 in Ewing's sarcoma family of tumors: Experience from a tertiary care cancer center.
    Murthy SS; Gundimeda SD; Challa S; Manjula V; Fonseca D; Rao VB; Rajappa SJ; N Raju KVV; Rao TS
    Indian J Pathol Microbiol; 2021; 64(1):96-101. PubMed ID: 33433416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.
    Syed M; Mushtaq S; Loya A; Hassan U
    Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and molecular spectrum of ewing sarcomas/PNETs, including validation of EWSR1 rearrangement by conventional and array FISH technique in certain cases.
    Rekhi B; Vogel U; Basak R; Desai SB; Jambhekar NA
    Pathol Oncol Res; 2014 Jul; 20(3):503-16. PubMed ID: 24293381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor.
    Folpe AL; Hill CE; Parham DM; O'Shea PA; Weiss SW
    Am J Surg Pathol; 2000 Dec; 24(12):1657-62. PubMed ID: 11117787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD99 and NKX2.2 positive neuroblastoma diagnosed on cytology: A potential diagnostic pitfall and necessity of pathological evaluation of the primary site.
    Aparna Devi C; Alashetty S; Champaka G; Dharmalingam P; Kapali A; Kumar N
    Diagn Cytopathol; 2023 Jun; 51(6):E189-E194. PubMed ID: 36999306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of NKX2.2 Immunohistochemistry for Distinguishing Ewing Sarcoma from Other Sinonasal Small Round Blue Cell Tumors.
    McCuiston A; Bishop JA
    Head Neck Pathol; 2018 Mar; 12(1):89-94. PubMed ID: 28616785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of PRKCB Immunohistochemistry as a Biomarker for the Diagnosis of Ewing Sarcoma.
    Zota V; Siegal GP; Kelly D; Bridge JA; Berglund A; Bui K; Khalil F; R Reed D; Altiok S; Magliocco A; Bui MM
    Fetal Pediatr Pathol; 2023 Apr; 42(2):241-252. PubMed ID: 36062956
    [No Abstract]   [Full Text] [Related]  

  • 15. NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma.
    Yoshida A; Sekine S; Tsuta K; Fukayama M; Furuta K; Tsuda H
    Am J Surg Pathol; 2012 Jul; 36(7):993-9. PubMed ID: 22446943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of EWSR1 gene rearrangement by fluorescence in situ hybridization in bone and soft tissue tumors: clinical application evaluation and atypical signal analysis].
    Li L; Zhang M; Zhang TT; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):458-463. PubMed ID: 38678326
    [No Abstract]   [Full Text] [Related]  

  • 17. NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls.
    Russell-Goldman E; Hornick JL; Qian X; Jo VY
    Cancer Cytopathol; 2018 Nov; 126(11):942-949. PubMed ID: 30376220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of the in situ hybridization with EWS dual-color break-apart fluorescence probe and anti-CD99 and anti-FLI-1 antibodies in the diagnosis of Ewing's sarcoma/primitive neuroectodermal tumor].
    Liu BY; Yang Y; DU J; Zhang Y; Wang H; Zheng J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):358-62. PubMed ID: 18677380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report and literature review of four cases of EWSR1::NFATC2 round cell sarcoma.
    Liu L; Li L; Ding Y; Kong F; Mo W; Ye H; Shen D
    Diagn Pathol; 2024 Jan; 19(1):19. PubMed ID: 38254207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors.
    Vural C; Uluoğlu O; Akyürek N; Oğuz A; Karadeniz C
    Pathol Oncol Res; 2011 Sep; 17(3):619-25. PubMed ID: 21267687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.